Europe · Wires & real time · Reuters US Markets

US judge won't block Eli Lilly ads for weight-loss drugs, rules against Novo Nordisk

Published by Reuters US Markets · United Kingdom 12 h ago

A US judge on Monday rejected Novo Nordisk's request to block ‌Eli Lilly from continuing weight-loss drug advertisements that the Danish drugmaker considered false and misleading.

Read the full article on Reuters US Markets Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.reuters.com)

Also worth reading

TASS

Russian forces introduce ceasefire in Kherson direction

Anadolu Agency

Iraq, Jordan sign 9 cooperation memorandums, programs in education, environment, economy

Reuters Technology

Anthropic discloses month-long training pause, AI security breaches in IPO filing

Reuters Business

AI scaling race accelerates investments in microgrid technology

Fastmarkets

Correction to CBAM Certificate Index and aluminium extrusion billet premium prices for October 22-23

Reuters